AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G] Sarepta Therapeutics,, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



D. E. Shaw & Co., L.P.
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:07/25/2025
David E. Shaw
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Attorney-in-Fact for David E. Shaw
Date:07/25/2025

Comments accompanying signature: Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
Exhibit Information

Exhibit 2: Joint Filing Agreement, by and among the Reporting Persons, dated July 25, 2025.

Sarepta Therapeutics Inc

NASDAQ:SRPT

SRPT Rankings

SRPT Latest News

SRPT Latest SEC Filings

SRPT Stock Data

1.78B
93.36M
4.42%
96.65%
15.12%
Biotechnology
Pharmaceutical Preparations
United States
CAMBRIDGE